Ebola Surge in Congo: Death Toll Climbs Past 1,600

The Ebola outbreak in eastern Congo has intensified, with the death toll linked to the Bundibugyo virus reaching at least 1,657 confirmed deaths. According to U.S. Centers for Disease Control data current as of August 1, 2026, total confirmed cases have surged to 3,748. This public health emergency, which began on May 15, is now recognized as the second-largest and fastest-growing Ebola outbreak in recorded history.

Response efforts remain severely hampered by insecurity in the Ituri province, which accounts for nearly 90% of the cases. Health teams face significant obstacles, including ongoing rebel violence, community distrust of medical personnel, and widespread protests by local healthcare workers regarding inadequate working conditions and unpaid benefits. The human cost is significant, with at least 36 frontline healthcare workers losing their lives to the virus, further straining the emergency medical response system in the five affected provinces.

Despite the ongoing containment struggles, there is a development in preventative efforts. Moderna has initiated its first human clinical trial for an experimental vaccine, mRNA-1469, in Canada. This vaccine utilizes the same mRNA platform technology as the company's previous COVID-19 vaccines and is designed specifically to target the Bundibugyo ebolavirus strain. Health Canada has authorized this early-stage study, which will enroll 80 healthy participants to evaluate safety and immune response, potentially offering a new tool for future outbreak management.